Bioceres Crop Solutions (BIOX) Expected to Post Earnings on Tuesday

Bioceres Crop Solutions (NASDAQ:BIOX) is expected to be posting its Q4 2026 results after the market closes on Tuesday, September 8th. Analysts expect the company to post earnings of ($0.06) per share and revenue of $79.00 million for the quarter. Investors may review the information on the company’s upcoming Q4 2026 earning summary page for the latest details on the call scheduled for Wednesday, September 9, 2026 at 12:30 PM ET.

Bioceres Crop Solutions Stock Up 3.5%

NASDAQ BIOX opened at $0.43 on Friday. The company has a current ratio of 0.88, a quick ratio of 0.70 and a debt-to-equity ratio of 0.57. The stock’s 50 day moving average is $0.37 and its two-hundred day moving average is $0.44. The company has a market capitalization of $27.44 million, a price-to-earnings ratio of -0.11 and a beta of 0.44. Bioceres Crop Solutions has a 1-year low of $0.30 and a 1-year high of $2.94.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Bioceres Crop Solutions from a “sell (d)” rating to a “sell (d-)” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $4.00.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several institutional investors have recently added to or reduced their stakes in BIOX. Bank of America Corp DE increased its holdings in shares of Bioceres Crop Solutions by 186.7% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after acquiring an additional 5,339 shares in the last quarter. PDT Partners LLC boosted its holdings in shares of Bioceres Crop Solutions by 58.9% in the 2nd quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after acquiring an additional 10,449 shares in the last quarter. Virtu Financial LLC bought a new stake in Bioceres Crop Solutions during the 3rd quarter worth approximately $40,000. Finally, Invesco Ltd. acquired a new stake in Bioceres Crop Solutions during the 4th quarter valued at $45,000. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.